Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test.

The aim of the study was to compare the response between the standard and low dose adrenocorticotropin (ACTH) test for patients with congenital adrenal hyperplasia (CAH). The authors employed a 2-by-2 crossover design and enrolled 16 patients, 14 girls and 2 boys, aged between 1.4 months and 15 years. Steroid treatment was stopped 24 hours before each test was conducted. The standard ACTH (250 microg) test was performed followed by the low dose test (1 microg) in eight patients; the other eight underwent the low dose ACTH test first followed by the standard one. The cortisol and 17-hydroxyprogesterone (17-OHP) levels in each patient varied unpredictably between the two tests. The cortisol responses to the low dose ACTH at 30 and 60 minutes were lower than at time zero; in contrast to the 60-minute peak cortisol response to the standard dose. The serum 17-OHP in all specimens was more than 10,000 ng/dl (300 nmol/L), with the peak response at 60 minutes in both groups. Both the low dose and standard dose ACTH test indicated adrenal insufficiency and the high 17-OHP levels were diagnostic of 21- hydroxylase (21-OH) deficiency. If the low dose ACTH test becomes the "standard" ACTH test, the diagnosis of 21-OH deficiency would probably not be missed.

Natural course of autoimmune thyroiditis in Thai children.

Forty-seven pediatric patients with autoimmune thyroiditis were followed for an average of 5.18+/-2.89 years. The diagnosis was based on a firm goiter and a positive test for antithyroid antibodies. Initially, 23 patients had euthyroidism, 11 overt hypothyroidism, 6 compensated hypothyroidism and 7 with low TSH. All patients had clinical euthyroidism, except two who had overt hypothyroidism. The thyroid function tests, the size of the thyroid gland and the thyroid antibodies were regularly evaluated. After the follow-up, 26 patients had untreated euthyroidism, 12 with overt hypothyroidism received eltroxin for maintenance of euthyroidism, while 4 had compensated hypothyroidism and 5 low TSH levels. All had clinical euthyroid. The thyroid size was reduced in 12 patients (26%) while 4 (9%) had normal-sized gland. The goiter size in 35 patients (74%) remained unchanged. The antithyroglobulin and antimicrosomal antibody titers fluctuated higher in patients with overt hypothyroidism. Eltroxin was given only to those having overt hypothyroidism with diminished goiter size in 8 patients (73%).

Changes in urinary chemical composition in healthy volunteers after consuming roselle (Hibiscus sabdariffa Linn.) juice.

The objective of this study was to evaluate the changes of urine in normal subjects after consuming roselle juice in different concentrations and durations which may help the treatment and prevention of renal stone disease. Thirty-six healthy men participated in the study, in which urinalysis, urine electrolytes and indices for measurements of concentration of urine were determined before, during and after roselle juice consumption. The urine after consumption of roselle juice showed a decrease of creatinine, uric acid, citrate, tartrate, calcium, sodium, potassium and phosphate but not oxalate in urinary excretion. The CPR values of the majority of each individual increased and means PI values decreased in phase 1. Contrarily, the CPR values of the majority of volunteers decreased and means PI values increased in phase 2. In conclusion a low dose of roselle juice (16 g/day) caused more significant decrease in salt output in the urine than a high dose (24 g/day). The urinary changes were similar to the observations on villagers with and without stones in northeastern Thailand.